SEC Tracker
Get the app

Aspen Neuroscience ASPE

ORBIMED ADVISORS LLC (Director) bought 1,000,000 ASPE at $15.00, worth $15M

Form
4
Filed
Importance
Major
  1. OrbiMed Advisors LLC acquired 196,541 common shares on Nov 2, 2026
  2. OrbiMed Advisors LLC acquired 642,745 common shares on Nov 2, 2026
  3. OrbiMed Advisors LLC acquired 616,984 common shares on Nov 2, 2026
  4. OrbiMed Advisors LLC acquired 1,000,000 common shares on Nov 2, 2026

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Aspen Neuroscience files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX